Arkolith/Insider Trading/TMDX/Form 4

Khayal Tamer I

Chief Commercial OfficerTransMedics Group, Inc. (TMDX) · full profile →Form 4 · filed Oct 3, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$438K
Net Open-Market Flow
-$438K
Transactions
15
12 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 1, 2024Option exercise(M)1K$38.46$56K22K
Oct 1, 2024Option exercise(M)417$66.10$28K23K
Oct 1, 2024Option exercise(M)1K$13.28$14K24K
Oct 1, 2024Sell(S)823$146.15$120K23K
Oct 1, 2024Sell(S)900$146.90$132K22K
Oct 1, 2024Sell(S)134$154.86$21K21K
Oct 1, 2024Sell(S)523$149.59$78K21K
Oct 1, 2024Sell(S)318$150.38$48K21K
Oct 1, 2024Sell(S)80$151.20$12K21K
Oct 1, 2024Sell(S)80$152.28$12K21K
Oct 1, 2024Sell(S)20$153.75$3K21K
Oct 1, 2024Sell(S)80$147.98$12K22K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 1, 2024Option exercise(M)417—$012K
Oct 1, 2024Option exercise(M)1K—$018K
Oct 1, 2024Option exercise(M)1K—$07K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-112394) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML